FDA approves first treatment Zelboraf (vemurafenib)for certain patients with Erdheim-Chester Disease, a rare blood cancer New Drug Approvals, 07 Nov 2017 FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood…